Here is my Q&A with Joe on 10/15/2019 conf call ab

Quote:

---

Steve: And now, I have a question about the MSO. I know you had to kind of turn it
off or slow it down while you cleaned up some things, and then you turned it
back on. Is that running full steam at this point, and are we going into some
additional states at this point? I think the last count was five, maybe six
states... how is that going along?
Joe: No. Right now, we've been focusing on the NASDAQ listing and our S-1...
raising money as an OTC company is never a pretty thing. So, to raise the
money necessary for what the next year needs would be, we'd much rather do
that as a NASDAQ company and moving into a NASDAQ listing. That's
what we've been doing. So, we've been focusing our assets right now, and our
capital into getting that NASDAQ listing, and doing all the appropriate legal
and other works. So, we're in a better position to raise money at much better
rates. And what we are doing is... right now, we're going to be closing on a
very large loan. That loan is non-dilutive, it's to build out our Arizona
operations. We have a partner that would be funding that, but it's not a stock
type of a deal, it's a regular loan based on business, that's going into those
markets. Non-dilutive, non-toxic fundraising is what we're most concerned
about, and that's what we're not doing.
Steve: But are some revenue is being generated at this point, I think I mean some
things just are picking up as normal, correct?
Joe: Oh, yeah, there's plenty of revenue coming; ALTuCELL is doing quite nicely
on revenues, they have new products that are coming out as well--with high
GENEREX_10152019
Page 15 of 28
demand. But the K is almost out, so you'll get the full picture of where we are
as per the financials real soon.

---